Lab Automation (TTA AND TLA) Market REPORT OVERVIEW
-
Request a Free Sample to learn more about this report
global lab automation (tta and tla) market size was USD 10750 million in 2022 and market is projected to touch 18778.94 Million by 2031, exhibiting a CAGR of 6.4% during the forecast period.
A multidisciplinary approach to research, development, optimization, and use of laboratory technologies that support new and enhanced procedures is laboratory automation. Task Targeted Automation (TTA) and Total Laboratory Automation (TLA) are the two types of lab automation (TLA). With TTA, a module will carry out particular process duties, such sorting and decapping. The samples must then be carried manually to the various analyzers, returned for post-analytics, and then placed in the refrigerator rooms. All of these steps take time and require human interaction.
Additionally, they have an impact on traceability because TTA samples occasionally sit dormant for a while. All of that is different with TLA solutions; all you have to do is load the samples in the format you need (in racks or bulk), and the TLA solution takes care of the rest. The samples are selectively prepared; as necessary, they are decapped, centrifuged, sent to the appropriate analyzers, sealed, stored, and disposed of as needed. By eliminating redundant, low-value tasks, this system also improves traceability, allowing you to know exactly where every sample has been and what has occurred to it along the route. Naturally, higher standards and more efficient resource use have a direct, favorable effect on patient safety and business results.
COVID-19 Impact: Halt on Manufacturing Operations to Slower Market Growth
The COVID-19 pandemic is the main factor affecting the lab automation (TTA and TLA) market for nowadays. In addition, the lab automation (TTA AND TLA) market saw a considerable decline in production as a result of the drop in laborers due to social distance rules during the COVID-19 pandemic. Due to supply chain challenges and restricted access to sites as a result of the COVID-19 epidemic, the majority of projects in China, the US, Germany, and South Korea are behind schedule. During the COVID-19 pandemic, the lab automation (TTA and TLA) market saw a drop in its market share. This is explained by the substantial decline in the industrial, automotive, and construction sectors.
LATEST TRENDS
"Improved Lab Efficiency to Boost Market Growth"
Growth in the lab automation (TTA and TLA) market is anticipated to be fueled by increased consumer desire to improve lab efficiency, boost capacity, and lower error. Clinical laboratories are always working to provide better services by speeding up turnaround and raising the caliber of their output. By offering consistency, thorough quality control, and fewer manual procedures, TLA helps labs solve these obstacles and, as a result, greatly improves laboratory performance. Clinical chemistry and haematology laboratories are the most prevalent users of TLA systems, with clinical microbiology usage increasing.
Lab Automation (TTA AND TLA) Market Segmentation
-
Request a Free Sample to learn more about this report
- By Type Analysis
As per the type, the market is classified as follows: Task Targeted Automation (TTA) and Total Laboratory Automation (TLA). The most lucrative lab automation (TTA and TLA) market share is anticipated to be Total Laboratory Automation (TLA).
- By Application Analysis
Based on application, the market is segmented as follows: Medical and Pharmaceutical Lab, Biology and Chemistry Lab, and Other Laboratories. Additionally, the biotechnology and pharmaceutical industries are anticipated to be the most lucrative application area in lab automation (TTA and TLA) market share.
DRIVING FACTORS
"Benefits of Automating Laboratory Procedures to Facilitate Market Development"
Automating laboratory procedures increases the overall effectiveness of experimental operations by accelerating tasks, decreasing waste, requiring fewer reagents, and enabling faster throughput of experiments. The running costs of the laboratory are decreased when these elements are merged. These elements should drive the lab automation (TTA and TLA) market forward. Automated technologies can also increase laboratory safety by using automated techniques to handle and store dangerous compounds. As a result, these risky reagents and operations are better avoided by laboratory staff. Automated technologies can also increase laboratory safety by using automated techniques to handle and store dangerous compounds. As a result, these risky reagents and operations are better avoided by laboratory staff.
"Increased Productivity due to Lab Automation (TTA and TLA) to Promote Industry Progress"
The laboratory world was interested in Task Targeted Automation because they were seeking for ways to increase productivity. The need for cost reduction is well understood by laboratory managers, and they are starting to understand that reallocating workers would have a bigger impact on their bottom line than reducing reagent prices by a few cents per test. Reduced turnaround times, decreased exposure to biohazards, increased staff productivity, improved sample tracking, effective archiving, and increased job satisfaction are all anticipated benefits of lab automation (TTA and TLA), all of which will improve patient care. In turn, this is anticipated to fuel the lab automation (TTA and TLA) market growth.
RESTRAINING FACTORS
"High Maintenance Costs to Hinder Market Growth"
However, the lab automation (TTA and TLA) market is constrained by a lack of planning for technological advancement, the fact that small- to medium-sized labs do not prioritize automation, and the absence of clear standards for data exchange and communication. The cost of maintenance is also high which is a major restraining factor of the lab automation (TTA and TLA) market.
Lab Automation (TTA AND TLA) Market REGIONAL INSIGHTS
-
Request a Free Sample to learn more about this report
"Increase in Demand to Propel Market Progress in North America"
During the projection period, North America is anticipated to be the most profitable area for lab automation (TTA and TLA) market. Sales of lab automation devices are rising as a result of the rising demand for clinical diagnostic processes. Because of the existence of major pharmaceutical corporations, there has been an increase in investment in the drug discovery and genomics markets. Major product manufacturers are expanding their distribution networks and manufacturing capacities to increase their penetration into emerging markets. A profitable potential for lab automation (TTA and TLA) is presented by this. The lab automation (TTA and TLA) market for is anticipated to grow as a result.
KEY MARKET PLAYERS
"Market Players Focus on New Product Launches to Strengthen Market Position"
Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and the launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.
List of Market Players Profiled
- Siemens Healthineers (Germany)
- Roche (Switzerland)
- Beckman Coulter (U.S.)
- BD (U.S.)
- IDS Co.,Ltd (Japan)
- Inpeco (Switzerland)
- Abbott (GLP Systems) (Germany)
- Autobio (China)
REPORT COVERAGE
The report covers overall market aspects, including the market segmentation based on its type and application. The report depicts a diverse group of participants that includes the market and the potential market leaders. Major factors that are expected to drive major growth in the market. The factors anticipated to expand the market share are also included in the report to offer market insights. The estimated growth of the market in the forecast period is also included in the report. The regional analysis is completed to explain the region's dominance in the global market. The factors hindering the growth of the market are discussed in detail. The SWOT analysis of the market is depicted in the report. It contains all-inclusive market details.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 10750 Million in 2022 |
Market Size Value By |
US$ 18778.94 Million by 2031 |
Growth Rate |
CAGR of 6.4% from 2022 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the lab automation (TTA and TLA) market expected to touch by 2031?
Based on our research, the lab automation (TTA and TLA) market is projected to touch USD 18778.94 Million by 2031.
-
What CAGR is the lab automation (TTA and TLA) market expected to exhibit by 2031?
The lab automation (TTA and TLA) market is expected to exhibit a CAGR of 6.4% by 2031.
-
Which are the driving factors of the lab automation (TTA and TLA) market?
The benefits of automating laboratory procedures and increased productivity due to lab automation (TTA and TLA) are the driving factors of the lab automation (TTA and TLA) market.
-
Which are the top companies operating in the lab automation (TTA and TLA) market?
Siemens Healthineers, Roche, Beckman Coulter, BD, IDS Co.,Ltd, Inpeco, Abbott (GLP Systems), and Autobio are the top companies operating in the lab automation (TTA and TLA) market.